1)CYFRA21-1细胞角蛋白19片段
1.Methods The level of TSGF, CYFRA21-1 and NSE in serum was measured in patients with lung cancer and benign lung disease by using Chromatometry of Biochemistry and Chemiluminoimmunoassay methods respectively.方法 采用生化比色法、电化学发光法检测肺癌及肺部良性病变患者血清中肿瘤特异性生长因子(TSGF)、细胞角蛋白19片段(CYFRA2 1 1)、神经元特异性烯醇化酶(NSE)的含量。
2.[Objective]To investigate the value of tumor supplied group factor(TSGF)and CYFRA21-1 in serum and bronchoalveolar lavage fluids(BALF)in the early diagnosis of lung Cancer.[目的]探讨血清和支气管肺泡灌洗液(BALF)中肿瘤相关物质群(TSGF)、细胞角蛋白19片段(CYFRA21-1)对肺癌早期诊断的价值。
3.To study diagnostic value of simultaneous detection of three markers,tumor markers tissue polypeptide specific antigen(TPS),neuro-specific enolase(CYFRA21-1)and carcino embryonic antigen(CEA) in patients with lung cancer.目的：探讨组织多肽特异性抗原(TPS)、细胞角蛋白19片段(CYFRA21-1)和癌胚抗原(CEA)三项标志物联合检测对非小细胞肺癌的诊断价值。
英文短句/例句
1.The Value of Cytokeratin 19 Fragment and Tissue Polypeptide Antigen Levels in Bronchoalveolar Lavage Fluid in Diagnosis of Lung Cancer;支气管肺泡灌洗液可溶性细胞角蛋白19片段和组织多肽抗原检测对肺癌的诊断价值
2.Abnormal expression of cytokeratins in hepatocellular carcinoma cell lines and induction of cytoderatin 19 expression by laminin;肝细胞癌细胞系的细胞角蛋白异常表达及层粘连蛋白对细胞角蛋白19表达的诱导
3.Expression of CK19 and its significance in breast cancer细胞角蛋白19基因扩增及过度表达的研究
4.Temporal spatial expression of alpha fetoprotein, cytokeratin-19 and c-Met during the process of human embryonic liver development of 3-12 weeks第3～12周人胚肝甲胎蛋白及细胞角蛋白19和c-Met的时空表达
5.Cytokeratins-19 Expression in Biopsy Specimens from Thyroid Neoplasm Detected by Flow Cytometry流式细胞术检测甲状腺穿刺组织细胞角蛋白-19的表达
6.Heterogeneous Expression of AFP and CK19 in Different Subpopulations of Hepatocellular Carcinoma Cells;肝癌细胞边缘群和非边缘群中甲胎蛋白和细胞角蛋白19的表达差异分析
7.Correlation of expression of cytokeratin 19-mRNA with invasion and metastasis in oral squamous cell carcinoma细胞角蛋白19-mRNA在口腔鳞癌侵袭转移中表达的意义
8.Matrix extracelluar phosphoglycoprotein and its important fragments细胞外基质磷酸糖蛋白及其重要的结构片段
9.Expression and Clinical Significance of GRIM-19 in Non-Small Cell Lung CancerGRIM-19蛋白在非小细胞肺癌的表达及其临床意义
10.Epithelial stem cells marker keratin 19 expression in residual skins after abrasion treatment of deep second-degree burn wounds深Ⅱ度烧伤创面磨痂治疗后残留皮肤组织中表皮干细胞标记物角化蛋白19的表达
11.The Study on Corneal Cell Sheet Engineering of Fibrin Glue and Its Adhesive Role for the Conjunctival Epithelium;纤维蛋白胶角膜细胞片及其对结膜上皮黏合作用的研究
12.The Study on Human Amniotic Epithelial Cell Sheet Engineering of Fibrin Gels and Its Re-establishment of Corneal Epithelium;纤维蛋白胶人羊膜上皮细胞片及其重建角膜上皮的研究
13.Study of HAb18G/CD147 Extracellular Portion Protein Refolding;HAb18G/CD147胞外片段蛋白质折叠复性研究
14.Preparation and Identification of exBTLA Protein and Anti-exBTLA Monoclonal Antibody;BTLA蛋白胞外区片段及其Mab的制备、鉴定
15.Expression of FHIT Protein in Lung Cancer by Cell Array肺癌中FHIT蛋白表达细胞芯片的研究
16.Study on the expression of cytokeratin 19 mRNA in oral squamous cell carcinoma细胞角蛋白19mRNA在口腔鳞状细胞癌中表达的研究
17.Abnormal expression of keratin in pterygial epithelium翼状胬肉上皮细胞异常表达角蛋白
18.cytoskeletal protein细胞骨架蛋白（质）
相关短句/例句
Cytokeratin 19 fragment细胞角蛋白19片段
1.To investigate clinical value of the combination detections of serum carcinoma-embryonic antigen (CEA),neuron specific enolase(NSE) and cytokeratin 19 fragment(CYFRA21-1) in patients with lung cancer.[目的]了解血清肿瘤标志物癌胚抗原(CEA)、神经元特异性烯醇化酶(NSE)和细胞角蛋白19片段(CYFRA21-1)在肺癌诊断中的应用价值。
2.OBJECTIVE:To assess the predictive and prognostic value of the decline in serum carcinoembryonic antigen (CEA) and cytokeratin 19 fragment (CYFRA21-1) during chemotherapy in patients with advanced non-small cell lung cancer (NSCLC).目的:评价晚期非小细胞肺癌(NSCLC)化疗后血清癌胚抗原(CEA)、细胞角蛋白19片段(CYFRA21-1)水平的下降在预测疗效及预后中的价值。
3.Objective Investigate the relationship between serum and pleural fluid CEA (carcinoembryonic antigen), CYFRA21-1 (cytokeratin 19 fragment), TSGF (tumor specific growth factor) in the diagnosis of malignant pleural applications.目的通过对血清及胸水中CEA(癌胚抗原)、CYFRA21-1(细胞角蛋白19片段)、TSGF(恶性肿瘤特异性生长因子)的检测,探讨此三项指标在恶性胸水诊断中的应用。
3)CYFRA211细胞角质蛋白19片段
1.Objective To study the diagnostic value of detection of adrenomedullin(AM) and combineddetection of with CYFRA211,NSE and CEA in differentiating malignant pleural effusion from tuberculosis pleural effusion,comparing with CYFRA211,NSE and CEA,to prove the experimental basis of differential diagnosis of malignant pleural effusion.目的以细胞角质蛋白19片段(CYFRA211)、神经元特异性烯醇化酶(NSE)、癌胚抗原(CEA)为对照,研究肾上腺髓质素(adrenomedullin AM)对恶性胸腔积液的鉴别诊断价值,并研究联合检测的临床意义,为结核性与恶性胸腔积液的鉴别诊断提供实验依据。
4)CYFRA21-1细胞角蛋白19血清片段21-1
1.Objective To appraise the values of tumor markers of SCC-Ag,CYFRA21-1,NSE and CEA in the diagnosis of lung cancer.目的探讨血清肿瘤标记物鳞状细胞癌相关抗原(SCC-Ag)、细胞角蛋白19血清片段21-1(CYFRA21-1)、神经元特异性烯醇化酶(NSE)、癌胚抗原(CEA)在肺癌临床诊断中的价值。
2.Aim:To evaluate the significance of combined detection of CK-19 mRNA,CEA,NSE,and CYFRA21-1 in clinical diagnosis of lung carcinoma.目的:评价外周血CK-19 mRNA与肿瘤标志物癌胚抗原(CEA)、神经元特异性烯醇酶(NSE)和细胞角蛋白19血清片段21-1(CYFRA21-1)联合检测对肺癌临床诊断的价值和意义。
5)CYFRA21 1细胞角蛋白19可溶性片段
6)Cyfra21-1水溶性细胞角蛋白19片段
1.Detection of CEA,Cyfra21-1,and NSE in serum and pleural fluid cancerous pleural effusion patients;癌性胸水患者血清和胸水中水溶性细胞角蛋白19片段、癌胚抗原和神经元特异性烯醇化酶检测
延伸阅读
抗淋巴细胞球蛋白 , 抗淋巴细胞免疫球蛋白,抗人胸腺淋巴细胞球蛋白药物名称：抗淋巴细胞球蛋白英文名：Antilymphocyte Globulin别名：抗淋巴细胞球蛋白 , 抗淋巴细胞免疫球蛋白,抗人胸腺淋巴细胞球蛋白外文名：Antilymphocyte Globuli ,ALG适应症： 1.适用于器官移植时的抗免疫排异治疗。用于人的同种异体移植有明显疗效，特别是对肾脏移植的病人。但也有一定局限性，主要是对急性排异期有效，对体液免疫所致的超急性排异无效。与硫唑嘌呤、泼尼松合用可提高脏器移植的成功率。骨髓移植时，供者与受者双方在术前均给以抗淋巴细胞球蛋白，有防止移植物抗宿主反应的作用。 2.自身免疫性疾病。ＡＬＧ对肾小球肾炎、红斑狼疮、类风湿性关节炎、重症肌无力等自身免疫性疾病有良好疗效，对顽固性皮炎、脉管炎、原发性肝炎、交感性眼炎等也有一定疗效 用量用法： 肌注：马ＡＬＧ每次每千克体重４～２０ｍｇ，兔ＡＬＧ每次每千克体重０．５～１ｍｇ，１日１次或隔日１次，１４日为１疗程。 静注：马ＡＬＧ每次每千克体重７～２０ｍｇ，稀释于５０～１００ｍｌ等渗盐水中，于４～６小时内滴完，输入适量等渗盐水，１日１次。 注意事项： 1.肌注可引起局部疼痛、红肿、发热、荨麻疹等，甚至有过敏性休克，静注也可有短时高热（３８～４０℃，持续３小时）、发冷，有时伴有关节痛和气短。静滴可见一过性体温升高与寒颤、低血压、心率增快等。一般在１～２小时内消退。 2.过敏体质者禁用，有急性感染者慎用。 3.采用ＡＬＧ治疗自身免疫性疾病应特别慎重，因长期应用使机体的免疫监管功能降低，给癌变细胞的发展以可乘之机。规格：冻干粉针剂:25mg(5ml)类别：免疫抑制剂
